Jul. 18 at 3:09 PM
$ARTV Google finance says : For Artiva Biotherapeutics Inc (NASDAQ:ARTV), analysts maintain a bullish outlook for the end of 2026, with an average price target of approximately
$39.00.
Forecasts from major firms range from a low of
$23.00 to a high of
$41.00.
As of July 17, 2026, the stock was trading at
$9.76, meaning the consensus target represents a potential upside of nearly 300%.
